Literature DB >> 12124353

Ras mediates radioresistance through both phosphatidylinositol 3-kinase-dependent and Raf-dependent but mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-independent signaling pathways.

Theresa M Grana1, Elena V Rusyn, Hong Zhou, Carolyn I Sartor, Adrienne D Cox.   

Abstract

Cells transformed by the oncogenic small GTPase, Ras, display a radioresistant phenotype in response to ionizing radiation (IR). To determine the mechanisms by which Ras mediates radioresistance in epithelial cells, we assessed the importance of three major survival pathways that can be activated by Ras [phosphatidylinositol 3-kinase (PI3-K)>Akt, nuclear factor kappaB (NF-kappaB), and Raf>mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK)>extracellular signal-regulated kinase] as necessary or sufficient for Ras-mediated radioresistance in matched pairs of RIE-1 rat intestinal epithelial cells expressing oncogenic Ras or empty vector (RIE-Ras and RIE-vector). Inhibiting PI3-K with LY294002 sensitized RIE-1 cells to IR in a dose-dependent manner, indicating that PI3-K is necessary for radioresistance, whereas inhibition of NF-kappaB with the super-repressor IkappaBalpha had little effect on survival. Expression of either the constitutively active catalytic subunit of PI3-K, p110alpha-CAAX, or the Ras effector domain mutant 12V/40C, which retains binding to PI3-K but is impaired in binding to other Ras effectors, was sufficient to confer partial radioresistance. Expression of either a constitutively active form of the serine/threonine kinase Raf-1 or the Ras effector domain mutant 12V/35S, which retains binding to Raf but is impaired in binding to other Ras effectors, was also sufficient to confer partial radioresistance. Surprisingly, however, even complete inhibition of MEK activity by using U0126 resulted in no change in post-IR survival whatsoever. Thus, whereas Raf contributes to Ras-mediated radioresistance, this is accomplished through a MEK-independent pathway. Taken together, these results indicate that multiple pathways, including both PI3-K-dependent and Raf-dependent but MEK-independent signaling, are required for Ras-mediated radioresistance in epithelial cells. Finally, we demonstrate that Ras-mediated radioresistance can be uncoupled from Ras-mediated transformation, in that PI3-K is required for radioresistance but not transformation, whereas MEK and NF-kappaB are required for transformation but not radioresistance in RIE-1 epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12124353

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  44 in total

1.  Mitogenic signalling in the absence of epidermal growth factor receptor activation in a human glioblastoma cell line.

Authors:  Meng Wang; Patrick Maier; Frederik Wenz; Frank Anton Giordano; Carsten Herskind
Journal:  J Neurooncol       Date:  2013-12       Impact factor: 4.130

2.  Repositioning HIV protease inhibitors as cancer therapeutics.

Authors:  Wendy B Bernstein; Phillip A Dennis
Journal:  Curr Opin HIV AIDS       Date:  2008-11       Impact factor: 4.283

3.  The protective role of interleukin-11 against neutron radiation injury in mouse intestines via MEK/ERK and PI3K/Akt dependent pathways.

Authors:  Leilei Yang; Ruijuan Wang; Yabing Gao; Xinping Xu; Kaifei Fu; Shaoxia Wang; Yang Li; Ruiyun Peng
Journal:  Dig Dis Sci       Date:  2014-01-23       Impact factor: 3.199

4.  IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response.

Authors:  Felipe J Núñez; Flor M Mendez; Padma Kadiyala; Mahmoud S Alghamri; Masha G Savelieff; Maria B Garcia-Fabiani; Santiago Haase; Carl Koschmann; Anda-Alexandra Calinescu; Neha Kamran; Meghna Saxena; Rohin Patel; Stephen Carney; Marissa Z Guo; Marta Edwards; Mats Ljungman; Tingting Qin; Maureen A Sartor; Rebecca Tagett; Sriram Venneti; Jacqueline Brosnan-Cashman; Alan Meeker; Vera Gorbunova; Lili Zhao; Daniel M Kremer; Li Zhang; Costas A Lyssiotis; Lindsey Jones; Cameron J Herting; James L Ross; Dolores Hambardzumyan; Shawn Hervey-Jumper; Maria E Figueroa; Pedro R Lowenstein; Maria G Castro
Journal:  Sci Transl Med       Date:  2019-02-13       Impact factor: 17.956

5.  Mutant KRAS Enhances Tumor Cell Fitness by Upregulating Stress Granules.

Authors:  Elda Grabocka; Dafna Bar-Sagi
Journal:  Cell       Date:  2016-12-15       Impact factor: 41.582

Review 6.  MicroRNA-21 is a novel promising target in cancer radiation therapy.

Authors:  Jia Liu; Hongcheng Zhu; Xi Yang; Yangyang Ge; Chi Zhang; Qin Qin; Jing Lu; Liangliang Zhan; Hongyan Cheng; Xinchen Sun
Journal:  Tumour Biol       Date:  2014-01-21

7.  Prostaglandin E2 reduces radiation-induced epithelial apoptosis through a mechanism involving AKT activation and bax translocation.

Authors:  Teresa G Tessner; Filipe Muhale; Terrence E Riehl; Shrikant Anant; William F Stenson
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

Review 8.  Clinical relevance of KRAS in human cancers.

Authors:  Sylwia Jancík; Jirí Drábek; Danuta Radzioch; Marián Hajdúch
Journal:  J Biomed Biotechnol       Date:  2010-06-07

9.  A phase I study of nelfinavir concurrent with temozolomide and radiotherapy in patients with glioblastoma multiforme.

Authors:  Michelle Alonso-Basanta; Penny Fang; Amit Maity; Stephen M Hahn; Robert A Lustig; Jay F Dorsey
Journal:  J Neurooncol       Date:  2013-11-06       Impact factor: 4.130

10.  Ionizing radiation-induced oxidative stress alters miRNA expression.

Authors:  Nicole L Simone; Benjamin P Soule; David Ly; Anthony D Saleh; Jason E Savage; William Degraff; John Cook; Curtis C Harris; David Gius; James B Mitchell
Journal:  PLoS One       Date:  2009-07-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.